Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.1.74 extracted from

  • Spasokoukotskaja, T.; Sasvari-Szekely, M.; Keszler, G.; Albertioni, F.; Eriksson, S.; Staub, M.
    Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity (1999), Eur. J. Cancer, 35, 1862-1867.
    View publication on PubMed

Activating Compound

Activating Compound Comment Organism Structure
1-beta-D-arabinosylcytosine i.e. cytarabine, 0.001 mM, stimulation Homo sapiens
2-chloro-2'-arabino-fluoro-2'-deoxyadenosine 0.001 mM, stimulation Homo sapiens
2-chloro-2'-deoxyadenosine i.e. cladribine, 0.001 mM, stimulation Homo sapiens
2-fluoro-1-beta-D-arabinosyladenine i.e. fludarabine, 0.001 mM, stimulation Homo sapiens
etoposide 0.001 mM, stimulation Homo sapiens
additional information not activating: 2-chloro-riboadenosine Homo sapiens

Localization

Localization Comment Organism GeneOntology No. Textmining

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
lymphocyte tonsillar lymphocyte Homo sapiens
-